Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010 (2010), Article ID 747946, 8 pages
http://dx.doi.org/10.1155/2010/747946
Clinical Study

Lower Extremity Ulcers in Systemic Sclerosis: Features and Response to Therapy

1Division of Rheumatology, Immunology and Allergy, Georgetown University Hospital, 3800 Reservoir Road, N.W., Hington, DC 20007, USA
2Centre for Biomedical Sciences, Cardiff School of Health Sciences, University of Wales Institute-Cardiff, Western Avenue, Cardiff CF5 2YB, UK
3Center for Wound Healing, Georgetown University Hospital, Washington, DC 20007, USA

Received 15 April 2010; Revised 15 June 2010; Accepted 2 July 2010

Academic Editor: Laura K. Hummers

Copyright © 2010 Victoria K. Shanmugam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Reidy, V. Steen, and J. J. Nicholas, “Lower extremity amputation in scleroderma,” Archives of Physical Medicine and Rehabilitation, vol. 73, no. 9, pp. 811–813, 1992. View at Google Scholar · View at Scopus
  2. S. Alivernini, M. De Santis, B. Tolusso et al., “Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing,” Journal of the American Academy of Dermatology, vol. 60, no. 3, pp. 426–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. D. Ramsey, K. Newton, D. Blough et al., “Incidence, outcomes, and cost of foot ulcers in patients with diabetes,” Diabetes Care, vol. 22, no. 3, pp. 382–387, 1999. View at Google Scholar · View at Scopus
  4. J. Hafner, E. Schneider, G. Burg, and P. C. Cassina, “Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease,” Journal of Vascular Surgery, vol. 32, no. 2, pp. 322–329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Milstone, I. M. Braverman, P. Lucky, and P. Fleckman, “Classification and therapy of atrophie blanche,” Archives of Dermatology, vol. 119, no. 12, pp. 963–969, 1983. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Miura and W. Torinuki, “Clinical course of atrophie blanche,” Journal of Dermatology, vol. 4, no. 6, pp. 259–262, 1977. View at Google Scholar · View at Scopus
  7. B. R. Hairston, M. D. P. Davis, M. R. Pittelkow, and I. Ahmed, “Livedoid vasculopathy: further evidence for procoagulant pathogenesis,” Archives of Dermatology, vol. 142, no. 11, pp. 1413–1418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. G. Heine and G. W. Davis, “Idiopathic atrophie blanche: treatment with low-dose heparin,” Archives of Dermatology, vol. 122, no. 8, pp. 855–856, 1986. View at Google Scholar · View at Scopus
  9. B. R. Hairston, M. D. P. Davis, L. E. Gibson, and L. A. Drage, “Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases,” Archives of Dermatology, vol. 139, no. 8, pp. 987–990, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. L. Jetton and G. S. Lazarus, “Minidose heparin therapy for vasculitis of atrophie blanche,” Journal of the American Academy of Dermatology, vol. 8, no. 1, pp. 23–26, 1983. View at Google Scholar · View at Scopus
  11. J. E. Salmon and G. Girardi, “Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation,” Journal of Reproductive Immunology, vol. 77, no. 1, pp. 51–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Girardi, P. Redecha, and J. E. Salmon, “Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation,” Nature Medicine, vol. 10, no. 11, pp. 1222–1226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. V. K. Shanmugam, V. D. Steen, and T. R. Cupps, “Lower extremity ulcers in connective tissue disease,” Israel Medical Association Journal, vol. 10, no. 7, pp. 534–536, 2008. View at Google Scholar · View at Scopus
  14. C. E. Attinger, J. E. Janis, J. Steinberg, J. Schwartz, A. Al-Attar, and K. Couch, “Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants,” Plastic & Reconstructive Surgery, vol. 117, no. 7S, pp. 72S–109S, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Ferri, D. Giuggioli, M. Sebastiani, and M. Colaci, “Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin,” Clinical and Experimental Dermatology, vol. 32, no. 3, pp. 287–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Hudson, B. D. Thombs, R. Steele et al., “Health-related quality of life in systemic sclerosis: a systematic review,” Arthritis Care & Research, vol. 61, no. 8, pp. 1112–1120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Speight, M. D. Reaney, and K. D. Barnard, “Not all roads lead to Rome: a review of quality of life measurement in adults with diabetes,” Diabetic Medicine, vol. 26, no. 4, pp. 315–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Price and K. Harding, “Cardiff Wound Impact Schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chronic wounds of the lower limb,” International Wound Journal, vol. 1, no. 1, pp. 10–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. Merkel, Y. Chang, S. S. Pierangeli, K. Convery, E. N. Harris, and R. P. Polisson, “The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases,” The American Journal of Medicine, vol. 101, no. 6, pp. 576–583, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Schoenroth, M. Fritzler, L. Lonzetti, and J.-L. Senécal, “Antibodies to β2 glycoprotein I and cardiolipin in SSc,” Annals of the Rheumatic Diseases, vol. 61, no. 2, pp. 183a–184, 2002. View at Google Scholar · View at Scopus
  22. A. Parodi, M. Drosera, L. Barbieri, and A. Rebora, “Antiphospholipid antibody system in systemic sclerosis,” Rheumatology, vol. 40, no. 1, pp. 111–112, 2001. View at Google Scholar · View at Scopus
  23. G. Zandman-Goddard, N. Tweezer-Zaks, T. Shalev, Y. Levy, M. Ehrenfeld, and P. Langevitz, “A novel overlap syndrome,” Annals of the New York Academy of Sciences, vol. 1108, pp. 497–504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Szamosi, Z. Csiki, E. Szomják et al., “Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage?” Clinical Reviews in Allergy and Immunology, vol. 36, no. 2-3, pp. 145–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Kobashi, K. Ohta, H. Yamada et al., “4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase,” Journal of Epidemiology, vol. 19, no. 6, pp. 275–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. O. Arcasoy, “The non-haematopoietic biological effects of erythropoietin,” British Journal of Haematology, vol. 141, no. 1, pp. 14–31, 2008. View at Publisher · View at Google Scholar · View at Scopus